加载中
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
最新数据
US$4.13
−US$0.02 · -0.48%
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
前收盘价
US$4.13
−US$0.02 · -0.48%
盘前
US$4.13
US$0.00 · 0.00%
10月13日 6:14 ET
盘中时间采用ET。市场数据可能有所延迟。
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
日内区间
当前US$4.13
52周区间
当前US$4.13
盘中时间采用ET。市场数据可能有所延迟。
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
日内区间
当前US$4.13
52周区间
当前US$4.13
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 1785.87万 USD | 2302.45万 USD | 3230.87万 USD | 4014.32万 USD | 4798.2万 USD |
| 销货成本 | 1155.76万 USD | 1695.26万 USD | 2199.36万 USD | 1825.18万 USD | 2265.59万 USD |
| 毛利 | 630.12万 USD | 607.19万 USD | 1031.51万 USD | 2189.13万 USD | 2532.62万 USD |
| 研究与开发 | 67.18万 USD | 303.11万 USD | 485.85万 USD | 762.33万 USD | 546.57万 USD |
| 销售、一般及管理费用 | 800.24万 USD | 1044.44万 USD | 900.09万 USD | 2129.5万 USD | 627.04万 USD |
| 营业费用 | 921.71万 USD | 1409.17万 USD | 1384.19万 USD | 2891.08万 USD | 1173.6万 USD |
| 利息支出 | 23.2万 USD | 27.82万 USD | 15.68万 USD | 16.24万 USD | 10.16万 USD |
| 折旧和摊销 | 51.74万 USD | 48.57万 USD | 50.88万 USD | 53.39万 USD | 44.69万 USD |
| 营业利润 | −291.59万 USD | −801.98万 USD | −352.68万 USD | −701.94万 USD | 1359.01万 USD |
| 净利润 | −367.21万 USD | −872.73万 USD | −616.31万 USD | −873.66万 USD | 1132万 USD |
公司数据更新于 2026年10月13日。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
